Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Stroke Prevention”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Early research (Phase 1)Study completedNCT04103034
What this trial is testing

A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers

Who this might be right for
Cerebrovascular StrokeLarge-Artery Atherosclerosis (Embolus/Thrombosis)Intracranial Arteriosclerosis
Band Therapeutics 112
Not applicableUnknownNCT05757635
What this trial is testing

A Research of Application of the New Model of Standardized Secondary Prevention of Stroke

Who this might be right for
Acute Ischemic Stroke
Peking Union Medical College Hospital 5,000
Not applicableStudy completedNCT03153020
What this trial is testing

Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône

Who this might be right for
StrokeTransient Ischemic Attack
Hospices Civils de Lyon 633
Testing effectiveness (Phase 2)Study completedNCT00885456
What this trial is testing

Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT

Who this might be right for
Transient Ischemic AttackNon-disabling Stroke
Marilyn MacKay-Lyons 187
Not applicableStudy completedNCT02238470
What this trial is testing

Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

Who this might be right for
Ischemic Stroke
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,000
Post-approval studies (Phase 4)Looking for participantsNCT05995600
What this trial is testing

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

Who this might be right for
Antiphospholipid SyndromeIschemic StrokeTransient Ischemic Attack+3 more
Seoul National University Hospital 200
Not applicableStudy completedNCT00843765
What this trial is testing

Efficiency Study of Traditional Chinese Medicine (TCM) Versus Western Medicine (WM) on Ischemic Stroke

Who this might be right for
Stroke
China Academy of Chinese Medical Sciences 1,151
Not applicableStudy completedNCT00660764
What this trial is testing

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca
Not applicableUnknownNCT02618265
What this trial is testing

Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research

Who this might be right for
Stroke
Peking University Third Hospital 400
Not applicableStudy completedNCT06450561
What this trial is testing

Adherence to Secondary Prevention Guidelines for Cardiovascular Risk

Who this might be right for
AtherosclerosisStroke, IschemicAcute Coronary Syndrome+2 more
Consorci Sanitari de l'Alt Penedès i Garraf 129
Not applicableUnknownNCT03228979
What this trial is testing

Secondary Prevention By Structured Semi-Interactive Stroke Prevention Package in INDIA (SPRINT INDIA) Study

Who this might be right for
Stroke
Christian Medical College and Hospital, Ludhiana, India 5,830
Not applicableStudy completedNCT01071408
What this trial is testing

Trial of a Secondary Stroke Prevention Program

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Sepulveda Research Corporation 54
Not applicableStudy completedNCT01466907
What this trial is testing

Secondary Prevention and Health Promotion After Stroke

Who this might be right for
Stroke
Skane University Hospital 597
Not applicableUnknownNCT05871528
What this trial is testing

Registry of Patients With Remote Posterior cErebral Hemorrhage Following Reperfusion Treatment in Ischemic Stroke

Who this might be right for
Ischemic StrokeIntracranial HemorrhagesHemorrhagic Transformation Stroke
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 250
Testing effectiveness (Phase 2)Study completedNCT03979781
What this trial is testing

Personalized Antiplatelet Secondary Stroke PRevenTion

Who this might be right for
Ischemic StrokeTIA
State University of New York - Upstate Medical University 90
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Not applicableLooking for participantsNCT06292117
What this trial is testing

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

Who this might be right for
Ischemic StrokeCYP2C19 Polymorphism
University of Virginia 350
Not applicableUnknownNCT02611440
What this trial is testing

Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke

Who this might be right for
Ischemic Stroke
Hospices Civils de Lyon 182
Not applicableStudy completedNCT01947998
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 50,299
Post-approval studies (Phase 4)Study completedNCT00153062
What this trial is testing

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Who this might be right for
Stroke
Boehringer Ingelheim 20,332
Load More Results